SMT201300133B - Nuove forme polimorfe di 6-(1-metil-1H-pirazol-4-IL)-2-[[3-[5-(-morfolin-4-IL-etossi)-pirimidin-2-IL]-benzil]]-2H-piridazin-3-one diidrogenofosfato e procedimenti per la loro produzione - Google Patents
Nuove forme polimorfe di 6-(1-metil-1H-pirazol-4-IL)-2-[[3-[5-(-morfolin-4-IL-etossi)-pirimidin-2-IL]-benzil]]-2H-piridazin-3-one diidrogenofosfato e procedimenti per la loro produzioneInfo
- Publication number
- SMT201300133B SMT201300133B SM201300133T SM201300133T SMT201300133B SM T201300133 B SMT201300133 B SM T201300133B SM 201300133 T SM201300133 T SM 201300133T SM 201300133 T SM201300133 T SM 201300133T SM T201300133 B SMT201300133 B SM T201300133B
- Authority
- SM
- San Marino
- Prior art keywords
- morfolin
- pyridazin
- pyrazol
- pyrimidin
- ethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08022253 | 2008-12-22 | ||
PCT/EP2009/008358 WO2010072295A1 (en) | 2008-12-22 | 2009-11-24 | Novel polymorphic forms of 6-(1-methyl-1h-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2h-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201300133B true SMT201300133B (it) | 2014-03-07 |
Family
ID=41609799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201300133T SMT201300133B (it) | 2008-12-22 | 2013-11-13 | Nuove forme polimorfe di 6-(1-metil-1H-pirazol-4-IL)-2-[[3-[5-(-morfolin-4-IL-etossi)-pirimidin-2-IL]-benzil]]-2H-piridazin-3-one diidrogenofosfato e procedimenti per la loro produzione |
Country Status (32)
Country | Link |
---|---|
US (1) | US8586599B2 (it) |
EP (1) | EP2361250B1 (it) |
JP (2) | JP5690741B2 (it) |
KR (1) | KR101663335B1 (it) |
CN (1) | CN102264729B (it) |
AR (1) | AR074686A1 (it) |
AU (1) | AU2009331990B2 (it) |
BR (1) | BRPI0923480B8 (it) |
CA (1) | CA2748218C (it) |
CL (1) | CL2011001278A1 (it) |
CO (1) | CO6331435A2 (it) |
CY (1) | CY1114659T1 (it) |
DK (1) | DK2361250T3 (it) |
EA (1) | EA019320B1 (it) |
EC (1) | ECSP11011219A (it) |
ES (1) | ES2434247T3 (it) |
HK (1) | HK1164837A1 (it) |
HR (1) | HRP20130993T1 (it) |
IL (1) | IL213647A (it) |
MX (1) | MX2011006682A (it) |
MY (1) | MY160526A (it) |
NZ (1) | NZ594172A (it) |
PE (1) | PE20120016A1 (it) |
PL (1) | PL2361250T3 (it) |
PT (1) | PT2361250E (it) |
SG (1) | SG172128A1 (it) |
SI (1) | SI2361250T1 (it) |
SM (1) | SMT201300133B (it) |
TW (1) | TWI448463B (it) |
UA (1) | UA103646C2 (it) |
WO (1) | WO2010072295A1 (it) |
ZA (1) | ZA201105394B (it) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008062826A1 (de) * | 2008-12-23 | 2010-07-01 | Merck Patent Gmbh | Pyridazinonderivate |
KR20180092096A (ko) | 2017-02-08 | 2018-08-17 | 에이비온 주식회사 | 트리아졸로 피라진 유도체의 신규한 다형체 및 이의 제조 방법 |
ES2946551T3 (es) | 2017-10-17 | 2023-07-20 | Palau Pharma S L U | Síntesis de compuestos de 4-aminopirimidina |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19604388A1 (de) | 1996-02-07 | 1997-08-14 | Merck Patent Gmbh | Arylalkyl-diazinone |
JPH10259176A (ja) | 1997-03-17 | 1998-09-29 | Japan Tobacco Inc | 血管新生阻害作用を有する新規アミド誘導体及びその用途 |
TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
AUPQ462299A0 (en) | 1999-12-13 | 2000-01-13 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
US6242461B1 (en) | 2000-01-25 | 2001-06-05 | Pfizer Inc. | Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
MXPA04003668A (es) | 2001-10-31 | 2004-07-22 | Merck Patent Gmbh | Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos. |
AU2003297431A1 (en) | 2002-12-20 | 2004-07-22 | Pharmacia Corporation | Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
BRPI0412003A (pt) | 2003-07-02 | 2006-08-15 | Sugen Inc | arilmetil triazol e imidazopirazinas como inibidores de c-met |
US7959919B2 (en) | 2003-11-19 | 2011-06-14 | Novelmed Therapeutics, Inc. | Method of inhibiting factor B-mediated complement activation |
US20070015771A1 (en) | 2004-07-29 | 2007-01-18 | Threshold Pharmaceuticals, Inc. | Lonidamine analogs |
US20070043057A1 (en) | 2005-02-09 | 2007-02-22 | Threshold Pharmaceuticals, Inc. | Lonidamine analogs |
TW200612918A (en) | 2004-07-29 | 2006-05-01 | Threshold Pharmaceuticals Inc | Lonidamine analogs |
WO2007044796A2 (en) | 2005-10-11 | 2007-04-19 | Nps Pharmaceuticals, Inc. | Pyridazinone compounds as calcilytics |
WO2007064797A2 (en) | 2005-11-30 | 2007-06-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
DE102005057924A1 (de) | 2005-12-05 | 2007-06-06 | Merck Patent Gmbh | Pyridazinonderivate |
US8030305B2 (en) | 2005-12-21 | 2011-10-04 | Janssen Pharmaceutica N.V. | Triazolopyridazines as kinase modulators |
WO2007130383A2 (en) | 2006-04-28 | 2007-11-15 | Northwestern University | Compositions and treatments using pyridazine compounds and secretases |
NL2000613C2 (nl) | 2006-05-11 | 2007-11-20 | Pfizer Prod Inc | Triazoolpyrazinederivaten. |
PE20121506A1 (es) | 2006-07-14 | 2012-11-26 | Amgen Inc | Compuestos triazolopiridinas como inhibidores de c-met |
US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
TW200922584A (en) | 2007-10-16 | 2009-06-01 | Novartis Ag | Organic compounds |
JP2011500778A (ja) | 2007-10-25 | 2011-01-06 | アストラゼネカ・アクチエボラーグ | ピリジン及びピラジン誘導体−083 |
AU2008319735A1 (en) | 2007-10-31 | 2009-05-07 | Nissan Chemical Industries, Ltd. | Pyridazinone derivatives and use thereof as P2X7 receptor inhibitors |
US8859580B2 (en) | 2007-11-16 | 2014-10-14 | Boehringer Ingelheim International Gmbh | Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
CL2008003785A1 (es) | 2007-12-21 | 2009-10-09 | Du Pont | Compuestos derivados de piridazina; composiciones herbicidas que comprenden a dichos compuestos; y método para controlar el crecimiento de la vegetación indeseada. |
WO2009080721A2 (en) | 2007-12-21 | 2009-07-02 | Palau Pharma, S. A. | 4 -aminopyrimidine derivatives as histamine h4 receptor antagonists |
EP2072506A1 (de) | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Thiazolyloxyphenylamidine oder Thiadiazolyloxyphenylamidine und deren Verwendung als Fungizide |
KR101610607B1 (ko) | 2007-12-21 | 2016-04-07 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 항바이러스 화합물 |
US7816540B2 (en) | 2007-12-21 | 2010-10-19 | Hoffmann-La Roche Inc. | Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
GB0725059D0 (en) | 2007-12-21 | 2008-01-30 | Syngenta Participations Ag | Novel pyridazine derivatives |
DE102007061963A1 (de) | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
AU2008339572B2 (en) | 2007-12-21 | 2012-05-10 | Astrazeneca Ab | Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
EP2234999A1 (en) | 2007-12-21 | 2010-10-06 | F. Hoffmann-La Roche AG | Heteroaryl derivatives as orexin receptor antagonists |
WO2009080364A1 (en) | 2007-12-21 | 2009-07-02 | Synthon B.V. | Raloxifene composition |
AR069869A1 (es) | 2007-12-21 | 2010-02-24 | Exelixis Inc | Derivados de benzofuro[3,2-d]pirimidinas inhibidores de proteinquinasas,composiciones farmaceuticas que los comprenden y usos de los mismos en el tratamiento del cancer. |
PE20091339A1 (es) | 2007-12-21 | 2009-09-26 | Glaxo Group Ltd | Derivados de oxadiazol con actividad sobre receptores s1p1 |
US8202996B2 (en) | 2007-12-21 | 2012-06-19 | Bristol-Myers Squibb Company | Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide |
CN101537006B (zh) | 2008-03-18 | 2012-06-06 | 中国科学院上海药物研究所 | 哒嗪酮类化合物在制备抗肿瘤药物中的用途 |
DE102008019907A1 (de) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
WO2009142732A2 (en) | 2008-05-20 | 2009-11-26 | Cephalon, Inc. | Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands |
DE102008028905A1 (de) | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
EP2323994A1 (en) | 2008-07-25 | 2011-05-25 | Boehringer Ingelheim International GmbH | Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
WO2010113986A1 (ja) | 2009-03-30 | 2010-10-07 | 住友化学株式会社 | ピリダジノン化合物の有害節足動物防除用途 |
AR082590A1 (es) | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
-
2009
- 2009-11-24 BR BRPI0923480A patent/BRPI0923480B8/pt active IP Right Grant
- 2009-11-24 AU AU2009331990A patent/AU2009331990B2/en not_active Ceased
- 2009-11-24 EA EA201100973A patent/EA019320B1/ru not_active IP Right Cessation
- 2009-11-24 CN CN200980151790.0A patent/CN102264729B/zh active Active
- 2009-11-24 MY MYPI2011002864A patent/MY160526A/en unknown
- 2009-11-24 DK DK09756445.4T patent/DK2361250T3/da active
- 2009-11-24 NZ NZ594172A patent/NZ594172A/xx not_active IP Right Cessation
- 2009-11-24 PT PT97564454T patent/PT2361250E/pt unknown
- 2009-11-24 US US13/141,142 patent/US8586599B2/en active Active
- 2009-11-24 PE PE2011001264A patent/PE20120016A1/es not_active Application Discontinuation
- 2009-11-24 SG SG2011043171A patent/SG172128A1/en unknown
- 2009-11-24 ES ES09756445T patent/ES2434247T3/es active Active
- 2009-11-24 SI SI200930754T patent/SI2361250T1/sl unknown
- 2009-11-24 KR KR1020117017081A patent/KR101663335B1/ko active IP Right Grant
- 2009-11-24 CA CA2748218A patent/CA2748218C/en active Active
- 2009-11-24 JP JP2011542688A patent/JP5690741B2/ja active Active
- 2009-11-24 PL PL09756445T patent/PL2361250T3/pl unknown
- 2009-11-24 MX MX2011006682A patent/MX2011006682A/es active IP Right Grant
- 2009-11-24 WO PCT/EP2009/008358 patent/WO2010072295A1/en active Application Filing
- 2009-11-24 UA UAA201109101A patent/UA103646C2/ru unknown
- 2009-11-24 EP EP09756445.4A patent/EP2361250B1/en active Active
- 2009-12-16 AR ARP090104909A patent/AR074686A1/es not_active Application Discontinuation
- 2009-12-21 TW TW098143944A patent/TWI448463B/zh not_active IP Right Cessation
-
2011
- 2011-05-31 CL CL2011001278A patent/CL2011001278A1/es unknown
- 2011-06-19 IL IL213647A patent/IL213647A/en active IP Right Grant
- 2011-06-22 CO CO11078454A patent/CO6331435A2/es active IP Right Grant
- 2011-07-21 EC EC2011011219A patent/ECSP11011219A/es unknown
- 2011-07-21 ZA ZA2011/05394A patent/ZA201105394B/en unknown
-
2012
- 2012-05-28 HK HK12105184.1A patent/HK1164837A1/xx not_active IP Right Cessation
-
2013
- 2013-10-21 HR HRP20130993AT patent/HRP20130993T1/hr unknown
- 2013-11-07 CY CY20131100991T patent/CY1114659T1/el unknown
- 2013-11-13 SM SM201300133T patent/SMT201300133B/it unknown
-
2014
- 2014-11-14 JP JP2014231392A patent/JP5860125B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI20071260A1 (it) | Procedimento di produzione di forme per la fabbricazione di calzature | |
LTPA2021002I1 (lt) | Kvinolono junginių gamybos būdas | |
IL239277A0 (en) | A method for identifying risk factors for diseases | |
EP2317849A4 (en) | PROCESS FOR THE TREATMENT OF LUNG DISEASES WITH RHO KINASE INHIBITOR COMPOUNDS | |
BRPI0909367A2 (pt) | calçado e método de fabricação do mesmo | |
EP2400969A4 (en) | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITORY COMPOUNDS | |
EP2157074A4 (en) | PROCESS FOR THE PRODUCTION OF ACROLEINE | |
IL205093A0 (en) | Method for production of nanofibres | |
SI2321295T1 (sl) | Derivati 4-(piridin-4-il)-1H-(1,3,5,)triazin-2-ona kot inhibitorji GSK3-beta za zdravljenje nevrodegenerativnih bolezni | |
SMT201400161B (it) | Nuove forme poliformiche di sale di idrocloruro di3-(1-[[3-[5-1-metil-piperidin-4il metossi)-pirimidin-2-il]-benzil]]-6-osso-1,6-didro-piridazin-3-il-benzonitrile e procedimenti per la sua produzione | |
EP2330220A4 (en) | METHOD FOR QUANTIFYING OR DETERMINING DNA | |
HK1132305A1 (en) | Manufacturing process of electrodes for electrolysis | |
FR2936475B1 (fr) | Procede de degradation de modes de freinage | |
EP2267143A4 (en) | METHODS FOR PRODUCING AMIDE COMPOUNDS | |
EP2142206A4 (en) | METHOD FOR THE TREATMENT OF ISCHEMIC ILLNESSES | |
IL210213A0 (en) | Process for the prepartion of benzoimidazol - 2 - yl pyrimidine derivatives | |
EP2130924A4 (en) | PROCESS FOR PRODUCING L-AMINO ACID OR NUCLEIC ACID | |
EP2327799A4 (en) | METHOD FOR DNA QUANTIFICATION OR DETECTION | |
SG10201404793VA (en) | Method of detaching semi-conductor layers at low temperature | |
EP1932910A4 (en) | PROCESS FOR THE PREPARATION OF MILKY ACID | |
IL193089A0 (en) | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof | |
FR2996941B1 (fr) | Procede de quantification des lesions cerebrales | |
SMT201300133B (it) | Nuove forme polimorfe di 6-(1-metil-1H-pirazol-4-IL)-2-[[3-[5-(-morfolin-4-IL-etossi)-pirimidin-2-IL]-benzil]]-2H-piridazin-3-one diidrogenofosfato e procedimenti per la loro produzione | |
GB0818921D0 (en) | Method of TOC monitoring | |
EP2310012A4 (en) | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIMIDINE DERIVATIVES |